Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
- Research interviews
-
1. The regulation of cell therapy
- Prof. Moutih Rafei
-
2. How and why neurons die in Alzheimer's disease?
- Prof. Bart De Strooper
-
3. The future of blood tests in cancer treatment
- Dr. Isaac Garcia-Murillas
-
4. Role of marketing authorization holder in drug safety
- Dr. Raphael Elmadjian Pareschi
-
5. Synthetic whole embryo models and their applications
- Prof. Jacob (Yaqub) Hanna
-
6. Scale-up challenges in the production of nanomedicines from lab to industry
- Prof. Dr. Oya Tagit
-
7. Artificial intelligence in precision medicine
- Dr. Michael P. Menden
-
8. Translational medicine: the risk of failure in delay and how to reduce it
- Prof. Martin Wehling
-
9. Challenges and solutions of scaling up
- Dr. Shaukat Ali
-
11. Management of generic drug development: challenges and opportunities
- Mr. Sandeep Patil
-
12. MassBank development and future
- Dr. Emma L. Schymanski
-
13. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
-
14. Translational research in amyotrophic lateral sclerosis (ALS)
- Prof. Aaron D. Gitler
-
16. PANDAS: a potential link between group A streptococcal infections and neurological disorders
- Prof. P. Patrick Cleary
-
17. Rheumatic diseases and musculoskeletal pain
- Prof. Anisur Rahman
-
18. Towards developing a universal influenza vaccine
- Prof. Peter Palese
- Clinical interviews
-
19. Monkeypox: etiopathogenesis, prevention, and treatments
- Dr. Dennis Hruby
-
20. Kidney xenotransplantation
- Dr. Douglas J. Anderson
-
21. CAR-T and TCR-T cellular immunotherapies in oncology
- Prof. Sebastian Kobold
-
22. MAPS: the business of medical affairs
- Dr. Danie du Plessis
-
23. Hypertrophic cardiomyopathy: therapies and treatments
- Prof. Srihari Naidu
-
24. Combating the HIV epidemic
- Prof. William Blattner
-
25. Epigenetic pharmaceuticals used in the clinic
- Dr. Thomas Paul
-
26. Precision cancer medicine: development and future
- Prof. Maurie Markman
-
27. Pediatric cancer testing
- Prof. Joshua Schiffman
-
28. Opposition to vaccination: a transatlantic discussion
- Prof. Jonathan Temte
-
29. Elective caesarean sections from an evolutionary perspective
- Prof. Wenda Trevathan
-
30. Antiphospholipid syndrome and Lupus
- Prof. Graham Hughes
-
31. Prescribing medications to children - a GP’s view
- Dr. Amanda Simmons
Topics Covered
- Xenotransplantation
- Kidney transplant
Biography
Dr. Douglas Anderson grew up in Franklin, Tennessee, just south of Nashville. He attended Vanderbilt University, where he received his bachelor’s and master’s degrees in biomedical engineering. After graduation, he remained at Vanderbilt to attend medical school before relocating to Atlanta in 2009. Once in Atlanta, he completed his residency in general surgery and fellowship in transplant surgery at Emory University. While there, he spent two years in the Emory Transplant Center laboratory researching co-stimulation blockade-based immunosuppression strategies in a pre-clinical model of kidney transplantation. At UAB, his clinical practice includes kidney and pancreas transplantation, as well as dialysis access. His research includes all areas of transplantation, including pre-clinical xenotransplantation studies, clinical trials, and outcomes research.
Links
Series:
Categories:
Therapeutic Areas:
External Links
- American Journal of Transplantation Article
- UAB's Xenotransplant team
- A doppler probe is used to assess blood flow inside the right porcine (pig) kidney after transplantation into the brain-dead recipient
- The porcine kidneys are prepared on the backbench for transplantation into the brain-dead recipient
- The surgical team prepares the abdomen of the brain-dead recipient for xenotransplantation
- The surgical team prepares the abdomen of the brain-dead recipient for xenotransplantation - alternate angle
- Picture of what the 10-gene edited pig kidney looked like prior to reperfusion in the UAB study
- Picture of what the 10-gene edited pig kidney looked like after reperfusion
- 2D Xenotransplant Animation
Talk Citation
Anderson, D.J. (2022, March 10). Kidney xenotransplantation [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/XEEX7785.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Douglas J. Anderson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.